OsteoarthritisMOVESNCT01423097
Magnitude of Osteoarthritis disadVantage on pEoples liveS
An observational study of Osteoarthritis, run by AstraZeneca at 1 site in Portugal.
Trial summary
Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age: Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain) Characterization of OA diagnosis in patients with self-reported OA Impact of self-reported OA… Read more about this study
- Who is it for?
- Ages 45 years and older
- Conditions the study is for
- Osteoarthritis
- How many people
- 1,015 participants
- Where
- 1 sitePortugal
- Study dates
- Sep 2011to Nov 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: community sample
Who may be able to join
- Adults over 45 years old with self-reported osteoarthritis
Who cannot join
- NA
Trial locations and contacts
1 site in 1 country.
About this study
Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:
- Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)
- Characterization of OA diagnosis in patients with self-reported OA
- Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)
- Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA
- Patient perception of impact of OA in its life and importance given to disease
Read the detailed description
Magnitude of Osteoarthritis disadvantage on peoples lives.
- Conditions
- Osteoarthritis
- Keywords
- osteoarthritis symptoms
- Medical subject headings
- Osteoarthritis
What is being measured
The primary outcome is the main question the study is designed to answer.
Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.
Measured: Single interview at the only one patient contact
Secondary outcomes (6)
Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.
Measured: Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.
Measured: Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.
Measured: Single interview at the only one patient contact
Characterization of OA diagnosis in patients with self-reported OA by direct interview.
Measured: Single interview at the only one patient contact
Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0
Measured: Single interview at the only one patient contact
Patient perception of impact of OA in its life and importance given to disease by direct interview.
Measured: Single interview at the only one patient contact
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Aug 2011 (estimated)
- Study startSep 2011
- Primary completionNov 2011
- Study completionNov 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- More trials run by AstraZenecaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
- Enrolment
- 1,015 participants (actual)
Sponsor and investigators
- Lead sponsor
- AstraZeneca
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01423097
- Sponsor's protocol ID
- NIS-RPO-XXX-2011/2
- Acronym
- MOVES
- Status last verified
- Oct 2012
- First submitted
- 24 Aug 2011
- Last updated
- 10 Oct 2012
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Oct 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Magnitude of Osteoarthritis disadVantage on pEoples liveS
- ClinicalTrials.gov ID
- NCT01423097
- Acronym / sponsor ID
- MOVES / NIS-RPO-XXX-2011/2
- Conditions
- Osteoarthritis
- Keywords
- osteoarthritis symptoms
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,015 participants (actual)
- Lead sponsor
- AstraZenecaIndustry (pharma, biotech, devices)
- Study start
- Sep 2011
- Primary completion
- Nov 2011 (actual)
- Study completion
- Nov 2011 (actual)
- First posted
- 25 Aug 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:
- Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)
- Characterization of OA diagnosis in patients with self-reported OA
- Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)
- Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA
- Patient perception of impact of OA in its life and importance given to disease
Detailed description
Magnitude of Osteoarthritis disadvantage on peoples lives.
Study design
- Observational model
- Ecologic or community
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 45 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- community sample
Key inclusion criteria (1 listed)
- Adults over 45 years old with self-reported osteoarthritis
Key exclusion criteria (1 listed)
- NA
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.
Time frame: Single interview at the only one patient contact
6 secondary outcomes
Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.
Time frame: Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.
Time frame: Single interview at the only one patient contact
Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.
Time frame: Single interview at the only one patient contact
Characterization of OA diagnosis in patients with self-reported OA by direct interview.
Time frame: Single interview at the only one patient contact
Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0
Time frame: Single interview at the only one patient contact
Patient perception of impact of OA in its life and importance given to disease by direct interview.
Time frame: Single interview at the only one patient contact
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Oct 2012.
Related trials for Osteoarthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Active, not recruiting
Effectiveness of Therapeutic Exercises on Spinopelvic Mobility
Osteoarthritis (OA) of the Hip
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis, run by AstraZeneca at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview. (time frame: Single interview at the only one patient contact). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Oct 2012.